Cantor Fitzgerald downgraded Cleveland BioLabs (NASDAQ: CBLI) from Buy to Hold with a price target of $2.00 (from $4.00).

This article: 173 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE